NP36124 Antibiotic, Antiviral & Genito Urinary Medicines
A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)
- Source
- Find a Tender
- Type
- Framework (Supply)
- Duration
- 2 year (est.)
- Value
- £30M
- Sector
- HEALTH
- Published
- 23 Apr 2024
- Delivery
- To 23 Apr 2026 (est.)
- Deadline
- n/a
Concepts
Location
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014
Geochart for 2 buyers and 57 suppliers
2 buyers
- NHS National Services Scotland NSS Edinburgh
39 suppliers
- Chiesi Manchester
- Flynn Pharma Stevenage
- Martindale Pharma Romford
- Pari Medical West Byfleet
- Pfizer Tadworth
- Ranbaxy London
- Viatris UK Healthcare Hatfield
- Bowmed Ibisqus Wrexham
- Glaxosmithkline Brentford
- Hameln Pharma Gloucester
- Esteve Pharmaceuticals Maidenhead
- Reig Jofre Bideford
- Sandoz Surrey
- Crescent Pharma Basingstoke
- Drugsrus Harrow
- Kent Pharmaceuticals Ashford
- Mercury Pharmaceuticals London
- Teva Castleford
- Accord Devon
- Aspire Pharma Petersfield
- Aventis Pharma Guildford
- Bbraun Medical Sheffield
- Bristol Laboratories Berkamsted
- CST Pharma Walsall
- DR Reddys Laboratories Cambridge
- Focus Pharmaceuticals Burton upon Trent
- Fresenius Kabi Runcorn
- Glenmark Pharmaceuticals Europe Watford
- Milpharm South Ruislip
- Morningside Pharmaceuticals Leicestershire
- Neon Healthcare Hertford
- Rosemont Pharmaceuticals Leeds
- RPH Pharma Cheadle
- Selective Supplies Haywards Heath
- Stada UK Thornton & Ross Huddersfield
- Tillomed Laboratories Luton
- Wockhardt Wrexham
- Zentiva Pharma London
- Biocon Pharma London
Description
Supply of Antibiotic, Antiviral & Genito Urinary Medicines to NHS Scotland.
Lot Division
| 1 | Antibiotic, Antiviral & Genito Urinary Medicines The Authority has awarded each product line within this Lot to a single Framework Participant. Award Criteria
| ||||||||
| 2 | Tobramycin, Colistimethate and Dornase Alfa Medicines for Inhalation Supply of Tobramycin, Colistimethate and Dornase Alfa Medicines for Inhalation to NHS Scotland. The Authority has awarded each product line as an unranked multi-supplier framework on a line by line basis to a maximum of six (6) Framework Participants. Award Criteria
| ||||||||
| 3 | Emergency Planning Antibiotics Supply of Emergency Planning Antibiotics to NHS Scotland. The Authority has awarded each product line within this Lot to a single Framework Participant. Award Criteria
| ||||||||
| 4 | Antibiotics for supply to the National NHS Pharmaceutical Specials Service (PSS) Supply of Antibiotics for supply to the National NHS Pharmaceutical Specials Service (PSS) to NHS Scotland. The Authority has awarded seventeen (17) product lines within this lot, each product line awarded to a Single Framework Participant. Award Criteria
| ||||||||
| 5 | Vancomycin 1g & 500mg powder for solution for infusion vials –single vials Supply of Vancomycin 1g & 500mg powder for solution for infusion vials –single vials to NHS Scotland. The Authority has awarded all presentations within this lot to a single Framework Participant. Award Criteria
| ||||||||
| 6 | Vancomycin 1g & 500mg powder for solution for infusion vials – 10 vial pack Supply of Vancomycin 1g & 500mg powder for solution for infusion vials – 10 vial pack to NHS Scotland. The Authority has awarded all presentations within this lot to a single Framework Participant. Award Criteria
| ||||||||
| 8 | Teicoplanin 200mg & 400mg powder and solvent for solution for injection vials – single vials Supply of Teicoplanin 200mg & 400mg powder and solvent for solution for injection vials – single vials to NHS Scotland. The Authority has awarded all presentations within this lot to a single Framework Participant. Award Criteria
|
Award Detail
| 1 | Chiesi (Manchester)
|
| 2 | Flynn Pharma (Stevenage)
|
| 3 | Martindale Pharma (Romford)
|
| 4 | Pari Medical (West Byfleet)
|
| 5 | Pfizer (Tadworth)
|
| 6 | Ranbaxy (London)
|
| 7 | Viatris UK Healthcare (Hatfield)
|
| 8 | Bowmed Ibisqus (Wrexham)
|
| 9 | Glaxosmithkline (Brentford)
|
| 10 | Hameln Pharma (Gloucester)
|
| 11 | Esteve Pharmaceuticals (Maidenhead)
|
| 12 | Reig Jofre (Bideford)
|
| 13 | Sandoz (Surrey)
|
| 14 | Crescent Pharma (Basingstoke)
|
| 15 | Drugsrus (Harrow)
|
| 16 | Glaxosmithkline (Brentford)
|
| 17 | Kent Pharmaceuticals (Ashford)
|
| 18 | Mercury Pharmaceuticals (London)
|
| 19 | Teva (Castleford)
|
| 20 | Bowmed Ibisqus (Wrexham)
|
| 21 | Drugsrus (Harrow)
|
| 22 | Drugsrus (Harrow)
|
| 23 | Accord (Devon)
|
| 24 | Aspire Pharma (Petersfield)
|
| 25 | Aventis Pharma (Guildford)
|
| 26 | Bbraun Medical (Sheffield)
|
| 27 | Bowmed Ibisqus (Wrexham)
|
| 28 | Bristol Laboratories (Berkamsted)
|
| 29 | Crescent Pharma (Basingstoke)
|
| 30 | CST Pharma (Walsall)
|
| 31 | DR Reddys Laboratories (Cambridge)
|
| 32 | Drugsrus (Harrow)
|
| 33 | Focus Pharmaceuticals (Burton upon Trent)
|
| 34 | Fresenius Kabi (Runcorn)
|
| 35 | Glaxosmithkline (Brentford)
|
| 36 | Glenmark Pharmaceuticals Europe (Watford)
|
| 37 | Hameln Pharma (Gloucester)
|
| 38 | Esteve Pharmaceuticals (Maidenhead)
|
| 39 | Kent Pharmaceuticals (Ashford)
|
| 40 | Mercury Pharmaceuticals (London)
|
| 41 | Milpharm (South Ruislip)
|
| 42 | Morningside Pharmaceuticals (Leicestershire)
|
| 43 | Neon Healthcare (Hertford)
|
| 44 | Pfizer (Tadworth)
|
| 45 | Ranbaxy (London)
|
| 46 | Reig Jofre (Bideford)
|
| 47 | Rosemont Pharmaceuticals (Leeds)
|
| 48 | RPH Pharma (Cheadle)
|
| 49 | Sandoz (Surrey)
|
| 50 | Selective Supplies (Haywards Heath)
|
| 51 | Teva (Castleford)
|
| 52 | Stada UK Thornton & Ross (Huddersfield)
|
| 53 | Tillomed Laboratories (Luton)
|
| 54 | Viatris UK Healthcare (Hatfield)
|
| 55 | Wockhardt (Wrexham)
|
| 56 | Zentiva Pharma (London)
|
| 57 | Biocon Pharma (London)
|
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Award on basis of price.
Other Information
The estimated value(s) referred to in Section II.1.5 and within all Lots cover(s) the twenty four (24) month contract duration and the twenty four (24) month extension period of the framework agreement. (SC Ref:763002)
Reference
- FTS 013200-2024